FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart

Desert Angels portfolio company, SynCardia Systems, Inc. has received FDA approval to launch an Investigational Device Exemption study into the effective use of the new 50cc SynCardia Heart. The 50cc heart is the smaller version of the 70cc SynCardia Heart, which is FDA, Health Canada and CE mark approved. It is designed for implantation in most women, smaller men and many adolescents with end-stage biventricular heart failure.

Click here for full article